Komipharm International Co., Ltd. (041960.KQ)
KRW 3815.0
(-1.55%)
KRW 3815.0
(-1.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 42.64 Billion | 39.8 Billion | 35.84 Billion | 37.16 Billion | 35.48 Billion |
| Cost of Revenue | 29.98 Billion | 28.34 Billion | 24.61 Billion | 23.78 Billion | 24.16 Billion |
| Gross Profit | 12.65 Billion | 11.45 Billion | 11.23 Billion | 13.37 Billion | 11.32 Billion |
| Operating Expenses | 18.93 Billion | 15.26 Billion | 16.52 Billion | 15.55 Billion | 23.66 Billion |
| Selling, General and Administrative Expenses | 4.67 Billion | 4.29 Billion | 3.54 Billion | 3.73 Billion | 10.09 Billion |
| Research and Development Expenses | 5.94 Billion | 2.53 Billion | 5.11 Billion | 3.26 Billion | 4.64 Billion |
| Other Expenses | 8.31 Billion | -2.89 Billion | -561.86 Million | -322.89 Million | - |
| Cost and Expenses | 48.92 Billion | 43.6 Billion | 41.13 Billion | 39.33 Billion | 47.82 Billion |
| Operating Income | -6.27 Billion | -3.8 Billion | -5.29 Billion | -2.17 Billion | -5.43 Billion |
| Interest Expense | 2.55 Billion | 2.21 Billion | 1.65 Billion | 1.54 Billion | 1.9 Billion |
| Income Tax Expense | 171.15 Million | -3.15 Billion | -767.33 Million | -1.51 Billion | 9.41 Billion |
| Earnings before Tax | -5.73 Billion | -7.47 Billion | -5.93 Billion | -3.95 Billion | -13.85 Billion |
| Net Income | -3.97 Billion | -6.51 Billion | -4.45 Billion | -2.81 Billion | -21.36 Billion |
| Earnings Per Share Basic | -57.00 | -84.49 | -63.60 | -40.08 | -305.45 |
| Earnings Per Share Diluted | -57.00 | -84.49 | -63.60 | -40.08 | -305.39 |
| Weighted Average Shares Outstanding | 69.8 Million | 77.09 Million | 70.11 Million | 70.25 Million | 69.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 69.8 Million | 77.09 Million | 70.11 Million | 70.25 Million | 69.95 Million |
| Gross Margin | 0.30 | 0.29 | 0.31 | 0.36 | 0.32 |
| EBIT Margin | -0.03 | -0.05 | -0.03 | 0.03 | -0.04 |
| Profit Margin | -0.09 | -0.16 | -0.12 | -0.08 | -0.60 |
| EBITDA | -1.33 Billion | -1.43 Billion | -1 Billion | 1.33 Billion | -1.57 Billion |
| Earnings Before Tax Margin | -0.15 | -0.10 | -0.15 | -0.06 | -0.15 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 19.15 Billion | 12.9 Billion | 42.64 Billion | 11.48 Billion | 7.83 Billion | 13.39 Billion |
| Cost of Revenue | 10.6 Billion | 7.88 Billion | 29.98 Billion | 9.47 Billion | 5.62 Billion | 8.63 Billion |
| Gross Profit | 8.55 Billion | 5.01 Billion | 12.65 Billion | 2.01 Billion | 2.21 Billion | 4.75 Billion |
| Operating Expenses | 3.01 Billion | 4.05 Billion | 18.93 Billion | 4.79 Billion | 3.54 Billion | 6.01 Billion |
| Selling, General and Administrative Expenses | 4.59 Billion | 1.51 Billion | - | 1.25 Billion | 995.14 Million | 1.32 Billion |
| Research and Development Expenses | 1.29 Billion | 378.02 Million | - | 1.19 Billion | 552.38 Million | 2.63 Billion |
| Other Expenses | -4.59 Billion | 113.35 Million | 457.92 Million | 455.63 Million | 78.15 Million | -105.33 Million |
| Cost and Expenses | 10.6 Billion | 11.93 Billion | 48.92 Billion | 14.26 Billion | 9.17 Billion | 14.64 Billion |
| Operating Income | 3.95 Billion | 965.28 Million | -6.27 Billion | -2.78 Billion | -1.33 Billion | -1.25 Billion |
| Interest Expense | - | 328.1 Million | 2.55 Billion | 730.2 Million | 758.47 Million | 347.18 Million |
| Income Tax Expense | -255.28 Million | -4.67 Million | 171.15 Million | 449.37 Million | 274.61 Million | -847.46 Million |
| Earnings before Tax | 4.83 Billion | 700.12 Million | -5.73 Billion | -1.23 Billion | -1.61 Billion | -1.59 Billion |
| Net Income | 5.09 Billion | 768.14 Million | -3.97 Billion | -1.01 Billion | -1.41 Billion | -726.45 Million |
| Earnings Per Share Basic | 72.83 | 11.00 | - | -15.24 | -22.18 | -10.35 |
| Earnings Per Share Diluted | 72.83 | 11.00 | - | -15.14 | -22.18 | -10.35 |
| Weighted Average Shares Outstanding | 69.74 Million | 69.83 Million | 69.8 Million | 66.41 Million | 63.74 Million | 70.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 69.74 Million | 69.83 Million | 69.8 Million | 66.85 Million | 63.74 Million | 70.16 Million |
| Gross Margin | 0.45 | 0.39 | 0.30 | 0.18 | 0.28 | 0.36 |
| EBIT Margin | 0.45 | 0.15 | - | -0.11 | 0.00 | -0.03 |
| Profit Margin | 0.27 | 0.06 | -0.09 | -0.09 | -0.18 | -0.05 |
| EBITDA | 8.55 Billion | 1.88 Billion | - | -1.25 Billion | 10.1 Million | -343.69 Million |
| Earnings Before Tax Margin | 0.21 | 0.07 | -0.15 | -0.24 | -0.17 | -0.09 |
RMGOF
CLI
UNIENTER
CASTROLIND
GEMSI
CBRG